Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Current Assets (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Current Assets for 6 consecutive years, with $101.9 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 58.61% to $101.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $101.9 million through Dec 2025, down 58.61% year-over-year, with the annual reading at $101.9 million for FY2025, 58.61% down from the prior year.
  • Current Assets for Q4 2025 was $101.9 million at Lexicon Pharmaceuticals, down from $122.5 million in the prior quarter.
  • The five-year high for Current Assets was $364.6 million in Q1 2024, with the low at $101.9 million in Q4 2025.
  • Average Current Assets over 3 years is $215.7 million, with a median of $234.6 million recorded in 2023.
  • The sharpest move saw Current Assets soared 232.87% in 2024, then crashed 58.61% in 2025.
  • Over 3 years, Current Assets stood at $176.5 million in 2023, then soared by 39.45% to $246.2 million in 2024, then tumbled by 58.61% to $101.9 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $101.9 million, $122.5 million, and $145.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.